Famina Hemani

Famina Hemani is an accomplished professional in drug safety and pharmacovigilance, currently serving as the Executive Director at Biosplice Therapeutics since May 2021. Prior experience includes positions as Director of Drug Safety and Pharmacovigilance at Neurocrine Biosciences and various roles at Shire, including Director and Associate Director of Aggregate Safety Reporting and Safety Analytics, respectively. Famina also held the position of Signal Detection Manager at Hospira, a Pfizer company, and worked as a Clinical Pharmacist at both One Point Patient Care and CVS Caremark Specialty Pharmacy. Famina earned a Doctor of Pharmacy (Pharm.D.) degree from Midwestern University between 2004 and 2007.